Market Tracker

08/30 8:53am ET

Valeant Pharmaceuticals International Inc (NYSE:VRX)

30.25
Delayed Data
As of Aug 29
 -0.58 / -1.88%
Today’s Change
18.55
Today|||52-Week Range
245.82
-70.24%
Year-to-Date
Valeant (VRX) Stock Falls on Lawsuit
Aug 29 / TheStreet.com - Paid Partner Content
Forget Mylan, Buy These 3 Drug Stocks Instead
Aug 26 / Zacks.com - Paid Partner Content
Healthcare Winners: Stryker Corp., UnitedHealth Group Inc.
Aug 29 / GuruFocus News - Paid Partner Content
Today's Good, Bad and Ugly
Aug 25 / TheStreet.com - Paid Partner Content
Bill Ackman Comments on Valeant
Aug 29 / GuruFocus News - Paid Partner Content
Here's A Reason Why Valeant (VRX) Stock Is Climbing Today
Aug 25 / TheStreet.com - Paid Partner Content
Pharma Has History of Price Gouging, Mylan Should Be No Surprise
Aug 26 / TheStreet.com - Paid Partner Content
Mallinckrodt Could Be Next in Spotlight Thanks to EpiPen Scrutiny
Aug 25 / TheStreet.com - Paid Partner Content
Bill Ackman: Valeant 'One Very Big Mistake'
Aug 26 / GuruFocus News - Paid Partner Content
EpiPen CEO: Blame the 'broken' system, not me
Aug 25 / CNNMoney.com

Today’s Trading

Previous close30.83
Today’s open30.85
Day’s range29.98 - 31.20
Volume19,088,304
Average volume (3 months)31,003,304
Market cap$10.3B
Dividend yield--
Data as of 08/29/2016

Growth & Valuation

Earnings growth (last year)-131.25%
Earnings growth (this year)-35.41%
Earnings growth (next 5 years)+11.00%
Revenue growth (last year)+26.42%
P/E ratioNM
Price/Sales3.32
Price/Book1.75

Competitors

 Today’s
change
Today’s
% change
PRGOPerrigo Company PLC+0.43+0.49%
MNKMallinckrodt Plc-0.72-0.96%
JAZZJazz Pharmaceuticals...-1.79-1.39%
RDYDr.Reddy's Laborator...+0.10+0.22%
Data as of 08/29/2016

Financials

Next reporting dateOctober 17, 2016
EPS forecast (this quarter)$1.80
Annual revenue (last year)$10.4B
Annual profit (last year)-$291.7M
Net profit margin-2.79%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chairman &
Chief Executive Officer
Joseph C. Papa
Chief Financial Officer &
Executive VP-Finance
Paul S. Herendeen
Corporate headquarters
Laval, Quă©bec

Forecasts